Spartan Capital Securities, LLC Partners with Lipella Pharmaceuticals Inc. for $1.72 Million Private Placement
Dec 18, 2024•7 months ago
Contract Type
partnership
Description
Spartan Capital Securities, LLC has successfully partnered with Lipella Pharmaceuticals Inc. for a $1.72 million private placement. The private placement involved the sale of up to 6,000,000 of Series B non-voting convertible preferred stock of Lipella Pharmaceuticals Inc.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months